WO1980002098A1 - Isoflavones and related compounds,methods of preparing and using and antioxidant compositions containing same - Google Patents
Isoflavones and related compounds,methods of preparing and using and antioxidant compositions containing same Download PDFInfo
- Publication number
- WO1980002098A1 WO1980002098A1 PCT/US1979/000347 US7900347W WO8002098A1 WO 1980002098 A1 WO1980002098 A1 WO 1980002098A1 US 7900347 W US7900347 W US 7900347W WO 8002098 A1 WO8002098 A1 WO 8002098A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- accordance
- oil
- antioxidant composition
- product
- Prior art date
Links
- 0 CC(C#CC(C1)O)=C1O* Chemical compound CC(C#CC(C1)O)=C1O* 0.000 description 5
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B5/00—Preserving by using additives, e.g. anti-oxidants
- C11B5/0021—Preserving by using additives, e.g. anti-oxidants containing oxygen
- C11B5/0035—Phenols; Their halogenated and aminated derivates, their salts, their esters with carboxylic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3544—Organic compounds containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
- C07C37/01—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis
- C07C37/055—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group
- C07C37/0555—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by replacing functional groups bound to a six-membered aromatic ring by hydroxy groups, e.g. by hydrolysis the substituted group being bound to oxygen, e.g. ether group being esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
- C07D311/38—2,3-Dihydro derivatives, e.g. isoflavanones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
- C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
- C07D311/40—Separation, e.g. from natural material; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
- C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
- C09K15/06—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen
- C09K15/08—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing oxygen containing a phenol or quinone moiety
Definitions
- tempeh a fermented soybean product obtained by fermenting soybeans with a fungus, either Rhizopus oligosporus or Rhizopus oryzae.
- Food products containing tempeh, such fish or fatty meat products exhibit improved stability, see U.S. Patent 3,681,085 (1972).
- a component of tempeh namely oil of tempeh, can recovered, see U.S. Patents 3,762,933 (1973) and 3,885,256 (1974), which exhibits enhanced antioxidant properties relative to those of tempeh.
- This oil of tempeh has been found to be useful in stabilizing a wide variety of edible oils a fats.
- the present invention involves the discovery that numerous isoflavones and related compounds which possess antioxidant properties may be recovered from tempeh. Other compounds which also are useful as antioxidants and/or as components antioxidant compositions can be prepared by chemical modification of those recovered from tempeh. Additionally, all of the compounds can be chemically synthesized.
- the compounds of this invention have the structure:
- dashed lines may be carbon-carbon single bonds carbon-carbon double bonds, and wherein X may be two hydrogen atoms or oxygen, and further wherein each of R, R' and R" may be a methyl or ethyl group or hydrogen.
- These compounds possess antioxidant properties and may be utilized in the stabilization of a wide variety of food products including edible fats and oils.
- texasin (6,7-dihydroxy-4'-methoxyisoflavone), genistein (5,7,4'-trihydroxyisoflavone), daidzein (7, 4'-dihydroxyisoflavone), glycitein (6 methoxy-7,4'-dihydroxyisoflavone), and the so-called "Murata" compound (6,7,4'-trihydroxyisoflavone).
- texasin has been found to be a particularly effective antioxidant.
- isoflavones having the structure
- dashed lines may be carbon-carbon single bonds or carbon-carbon double bonds, and wherein X may be two hydrogen atoms or oxygen, and further wherein R, R' and R" may be a methyl or ethyl group or hydrogen have been found to be useful as antioxidants and as components of antioxidant compositions.
- Compounds II are natural products which may be recovered from tempeh, an Indonesian foodstuff, by fermentation of soybeans with a fungus, e.g. either Rhizopus oligosporus ATCC No. 22959 or Rhizopus oryzae ATCC No.9363.
- Compounds II are typically present a mixture in tempeh and are most readily recovered therefrom the form of a mixture from which the individual compounds can subsequently be isolated.
- Compounds II are known compounds, such as for example, texasin (6,7-dihydroxy4'-methoxyisoflavone), genistein (5,7,4'-trihydroxy isoflavone), daidzein (7,4'-dihydroxyisoflavone), glycitein (6 methoxy-7, 4'-dihydroxyisoflavone), and the so-called “Murata" compound (6,7,4'-trihydroxyisoflavone).
- texasin (6,7-dihydroxy4'-methoxyisoflavone)
- genistein 5,7,4'-trihydroxy isoflavone
- daidzein (7,4'-dihydroxyisoflavone)
- glycitein (6 methoxy-7, 4'-dihydroxyisoflavone
- Murata 6,7,4'-trihydroxyisoflavone
- Compounds III a novel compounds useful as antioxidants and as components of antioxidant compositions.
- antioxidant compositions may be prepared which include one or more of Compounds I and a suitable carrier.
- antioxidant compositions which include one or more of Compounds III and/or V provide exceptional antioxidative properties as set forth in the examples hereinafter.
- Suitable carriers include essentially all non-toxic substances with which the compounds may be admixed or in which they may be dissolved and/or suspended.
- the carrier may be the same or another compatible oil or fat.
- the amount of the compound or compounds present in the composition may vary within a wide range limited only by the requirement that the amount be effective to provide antioxidant properties to the composition. Typically, amounts will range from about 0.001 to 10 percent by weight.
- Stabilized edible fat or oil compositions may be prepared by adding thereto an antioxidant composition which includes one or more of compounds I in an amount effective to stabilize such edible fat or oil.
- Effective amounts of such antioxidant compositions for improving the stability of oils or fats are amounts in the range of about 0.01 to 1.0 percent by weight, more or less.
- antioxidant compositions can also be included in food products to produce stabilized food compositions. Accordingly, food products, such as fish, fatty meat or derivatives thereof, may be stabilized by the addition thereto of an effective amount of an antioxidant composition such as described hereinabove. Effective amounts may typically range from 0.001 to 10 percent by weight, preferably 0.01 to 1.0 percent.
- Compounds II and certain of Compounds III are produced by fermentation of soybeans with a fungus, e. g. , R. ligosporus or R. oryzae.
- Compounds II may then be recovered in the following manner. Dry, e.g. lyophilized, tempeh powder or cultured fungus is contacted with a 60-70% aqueous methanol solution for an extended period of time, for example, overnight, at a temperature of about 4°C. thereby producing an extract of methanol-soluble components including one or more of the isoflavones II.
- the methanol extract solution after removal of insoluble material, is evaporated to dryness, preferably in vacuo, at an elevated temperature, for example, about 40-60°C.
- a solid residue is produced most of which is redissolved upon contact with dry methanol. That portion of the residue which is methanol insoluble is separated from the soluble components by centrifugation and discarded. After centrifugation, the methanol supernatant is extracted with haxane several times, for example, two to three times, in order to remove any traces of hexane-soluble impurities, such as lipids.
- the remaining methanol supernatant is evaporated to reduce its volume to a minimal fraction, for example, about 20 ml, and kept at a temperature of about -20°C. for about 15-20 minutes. This results in formation of additional precipitate which is removed and discarded.
- the isoflavones may then be recovered from the methanol supe natant or extract as follows.
- the supernatant is subjected to molecular sieve chromatography, for example, chromatograp on Sephadex LH20 using a suitable size column, for example 2 ⁇ 40cm, and a suitable mobile phase, for example, n-propanol ethylacetate:water in a ratio 5:5:1.
- a suitable matrix for example, silica gel
- ethylace tate:propanol:water 95:2:3.
- Each of the isoflavones can then be recovered in essentially pure form using its differential mobility on the silica gel plate.
- Compounds II can be chemically synthesized by forming a suspension of a compound having the structure
- each of R and R' may be either hydrogen or an ethyl or methyl group and a compound having the structure
- R" may be hydrogen, methyl or ethyl in dry ethylether containing zinc chloride.
- This suspension is then exposed to dry hydrogen chloride for a sufficient time to form an oily product.
- the suspension is next maintained at an appropriate temperature for a sufficient time to permit the oil product formed upon exposure to dry hydrogen chloride to separate from the suspension.
- the supernatant remaining after separation of the oil product from the suspension is removed and discarded.
- a major amount of water and a minor amount of concentrated hydrochloric acid is added to the oil product to form a mixture, the mixture is boiled under reflux for a sufficient time to produce a precipitate product having the structure
- Compounds III can be prepared by hydrogenating Compounds II using conventional techniques such as contact with hydrogen gas in the presence of a catalyst under appropriate conditions of temperature, pressure and the like.
- Compounds V can be prepared by hydrogenating Compounds III and/or II.
- 6 , 7-dihydroxy-3- (4-methoxyphenyl) chroman is the most effective of the antioxidants tested.
- 6 , 7-dihydroxy-3- (4-methoxyphenyl) chromanon-4 is better than ⁇ -tocopherol, but less effective than TBHQ and comparable with BHA and BHT.
- Example 1 The compounds tested in Example 1, namely, 6,7-dihydroxy-3-(4-methoxyphenyl) chroman and 6,7-dihydroxy-3-(4-methoxyphenyl) chromanon-4, were also tested to evaluate their effect upon the taste of normal quality lard, bean oil and palm. oil.
- the compounds were added to the lard or oil at amounts ranging from 25-200 mg/kg and stored at 15°C. or 50oC in the dark. The lard or oil was then tasted periodically over a 14-week period. It was found that 6,7-dihydroxy-3-(4-methoxyphenyl)chromanon-4 favorably influenced the taste of the lard and oils. Addition of 6,7-dihydroxy-3-(4-methoxyphenyl) chroman imparted an off-taste although this may be due to the presence of an impurity.
- EXAMPLE 7 An antioxidant composition was obtained from tempeh which included Texasin and additional isoflavones having the structure wherein R, R' and R" may be a methyl or ethyl group or hydrogen. This mixture of isoflavones was evaluated using the Swift Stability Test described hereinabove at 110°C. Lard samples containing 500, 50 and 1 ppm of the mixture were prepared by suitable dilutions of a stock mixture of the isoflavone mixture dissolved in 1:1 chloroform-methanol and the mixture was evaporated under vacuum to a clear solution. A similar set of lard samples containing BHT was also prepared for comparison Results of the test are shown in Table IV.
- the isoflavone mixture at 50 ppm and 1 ppm produced no significant increase in stability. With the 500 ppm sample, however, the stability was comparable to that of the 50 ppm BHT sample. Thus, the isoflavone mixture has antioxidant properties, but its activity is less than that of BHT under conditions of the test. It should be noted that this test is not completely suitable for evaluating isoflavones under all conditions because of the severity of the conditions used (temperature 110°C. with air bubbled through the sample).
- each of the isoflavones has a oxidant properties. Particularly effective is the isoflavon mixture obtained by chemical synthesis which includes various methoxy- substituted isoflavones. Also, the compound 6,4'-dimethoxy-7-hydroxyisoflavone was particularly effective.
- Example 12 It was characterized by UV, NMR, IR and Mass spectroscopy and determined to be 6,7-dihydroxy-3-(4-methoxyphenyl)chroman. As in Example 12, the product is actually a mixture of optical isomers but since the isomers exhibit the same properties further characterization was not deemed necessary for the purposes of this disclosure. Therefore, it is to be understood that the scope of the disclosure and claims embraces the optical isomers of the compounds discussed herein.
- 1,4 benzoquinone (XI) was slowly added with stirring to a mixture of 150 g of acetic anhydride and 3 ml of cone, sulfuric acid during which the reaction mixture was cooled so as to keep the temperature between 40 and 50°C. After all of the quinone was dissolved and the heat of formation evolved, the reaction product was washed with an excess of water and the precipitate removed by filtration. Upon drying the precipitate 1,2,4-triacetoxybenzone (XII) was obtained as a light brown powder which can be identified as such after crystallization from methanol. The yield from the reaction was 106 g (91%).
- 6,7-dihydroxy-isoflavone may be hydrogenated using the methods described in Examples 12 and 13 to prepare the chromanon-4 and chroman respectively. Both of these compounds have been found effective as antioxidants at concentrations as low as 50 parts per million in the standard lard test described in Example 1.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Microbiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fats And Perfumes (AREA)
- Edible Oils And Fats (AREA)
- Anti-Oxidant Or Stabilizer Compositions (AREA)
- Pyrane Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Isoflavones and related compounds useful as antioxidants and in antioxidant compositions including edible fats and oils. Many of these compounds can be recovered from tempeh, a fermented soybean product, Others can be prepared by chemical modification of those recovered from tempeh. Additionally, all of the compounds can be chemically synthesized. The compounds of the present invention may be used to provide enhanced stability for a wide range of substances subject to oxidative deterioration including edible food products, oils and fats.
Description
ISOFLAVONES AND RELATED COMPOUNDS, METHODS OF PREPARING AND USING AND ANTIOXIDANT COMPOSITIONS CONTAINING SAME
BACKGROUND OF THE INVENTION
This is a continuation-in-part of application Serial No. 804,594, filed June 8, 1977, the disclosure of which is hereby incorporated by reference into the present disclosure.
Many food products containing and including edible fats and oils, i.e., fats and oils of animal and vegetable origin or modified fats and oils of animal and vegetable origin, become rancid or have an undesirable taste and/or color imparted thereto during storage, especially upon exposure to or on contact with oxygen. A number of chemical compounds have been employed for avoiding or reducing these effects so that food products containing fats or oils may be kept for longer periods of time, but such agents have not been entirely satisfactory or effective in many cases. Furthermore, such chemical compounds are usually synthetic chemical products not derived from or identical with material of natural food classifications and, as a consequence, there has been some question as to the advisability of using such compounds in food compositions.
Principal antioxidants of the above kinds heretofore employed included BHA (butylated hydroxyanisole), BHT (butylated hydroxytoluene) and TBHQ (tertiary butylhydroquinone), as well as some other chemicals of which one example is propyl gallate (PG). While these materials have been quite effective in animal fats, su.cn as lard, they are much less useful in some other applications. Their volatility and tendency to decompose at high temperatures makes them not entirely suitable for deep fat fried foods. Indeed, their usefulness for stability of vegetable oils is less than satisfactory. For example, they are not entirely effective in protecting against off-flavor development, such as the so-called reversion flavor, that occurs, with passage of time, in soybean oil. For these and other reasons, there has been a need for improvement in the field of antioxidants, especially those to be used with
food materials that comprise or consist of fats or oils.
It has been heretofore known that antioxidant properties are possessed by tempeh, a fermented soybean product obtained by fermenting soybeans with a fungus, either Rhizopus oligosporus or Rhizopus oryzae. Food products containing tempeh, such fish or fatty meat products exhibit improved stability, see U.S. Patent 3,681,085 (1972). Further, it has heretofore been found that by extracting tempeh with a mixture of hexane an methanol, a component of tempeh, namely oil of tempeh, can recovered, see U.S. Patents 3,762,933 (1973) and 3,885,256 (1974), which exhibits enhanced antioxidant properties relative to those of tempeh. This oil of tempeh has been found to be useful in stabilizing a wide variety of edible oils a fats.
SUMMARY OF THE INVENTION
The present invention involves the discovery that numerous isoflavones and related compounds which possess antioxidant properties may be recovered from tempeh. Other compounds which also are useful as antioxidants and/or as components antioxidant compositions can be prepared by chemical modification of those recovered from tempeh. Additionally, all of the compounds can be chemically synthesized. The compounds of this invention have the structure:
wherein the dashed lines may be carbon-carbon single bonds
carbon-carbon double bonds, and wherein X may be two hydrogen atoms or oxygen, and further wherein each of R, R' and R" may be a methyl or ethyl group or hydrogen.
These compounds possess antioxidant properties and may be utilized in the stabilization of a wide variety of food products including edible fats and oils.
Of these compounds those having the structure
Of the compounds so recovered certain are known compounds, such as for example, texasin (6,7-dihydroxy-4'-methoxyisoflavone), genistein (5,7,4'-trihydroxyisoflavone), daidzein (7, 4'-dihydroxyisoflavone), glycitein (6 methoxy-7,4'-dihydroxyisoflavone), and the so-called "Murata" compound (6,7,4'-trihydroxyisoflavone). However, the fact that these compounds possess antioxidant properties is a new discovery. Of these compounds, texasin has been found to be a particularly effective antioxidant.
Also, certain compounds having the structure
may be recovered from tempeh in minor amounts. However, these compounds are obtained in higher yield upon chemical modification, specifically hydrogenation, of compounds II. Of the compounds III, the compound having the structure
has been found to be particularly effective, All of the compounds III are novel.
Compounds having the structure
is the most effective of the antioxidants which have been evaluated. All of the Compounds V are also novel.
These Compounds I through VI may be chemically synthesized as well as recovered from tempeh. Thus, in addition to providing compounds useful as antioxidants and in antioxidant compositions, the present invention provides methods of preparing and/or recovering the compounds disclosed.
It is therefore a primary object of the present invention to provide compounds useful as antioxidants.
It is a related object to provide antioxidant compositions which include these compounds.
It is a further related object to provide edible oils, fats and other food products which include these antioxidant compositions.
It is another object of this invention to provide methods of stabilizing edible oils, fats or foods by including in suchoils, fats or foods an effective amount of an antioxidant composition.
It is a final object to provide methods of recovering and/or preparing compounds useful as antioxidants.
How these and other objects of this invention are accomplished will become apparant upon reading the detailed description of the invention including the examples set forth, and the claims which follow. In at least one embodiment of the present invention at least one of the foregoing objects will be achieved.
DETAILED DESCRIPTION OF THE INVENTION
In accordance with one embodiment of this invention, isoflavones having the structure
wherein the dashed lines may be carbon-carbon single bonds or carbon-carbon double bonds, and wherein X may be two hydrogen atoms or oxygen, and further wherein R, R' and R" may be a methyl or ethyl group or hydrogen have been found to be useful as antioxidants and as components of antioxidant compositions.
Certain of these compounds , namely those having the structure
are natural products which may be recovered from tempeh, an Indonesian foodstuff, by fermentation of soybeans with a fungus, e.g. either Rhizopus oligosporus ATCC No. 22959 or Rhizopus oryzae ATCC No.9363. Compounds II are typically present a mixture in tempeh and are most readily recovered therefrom
the form of a mixture from which the individual compounds can subsequently be isolated.
Compounds encompassed within Structure II as well as within the other structures herein may include stereoisomers and optical isomers. For purposes of this disclosure, no distinction will be made among such isomers so that it is to be understood that the disclosure and claims set forth hereinafter embrace all of the isomers encompassed within the structural formulas indicated. Certain of Compounds II are known compounds, such as for example, texasin (6,7-dihydroxy4'-methoxyisoflavone), genistein (5,7,4'-trihydroxy isoflavone), daidzein (7,4'-dihydroxyisoflavone), glycitein (6 methoxy-7, 4'-dihydroxyisoflavone), and the so-called "Murata" compound (6,7,4'-trihydroxyisoflavone). However, in accordance with the present invention it has been discovered that these compounds possess antioxidant properties. Of these compounds, texasin, which has the structure
In addition to Compounds II, additional compounds having the structure
are present in tempeh in minor amounts and may be recovered
therefrom. However, these compounds are obtained in higher yeild upon chemical modification, specifically, hydrogenation, of Compounds II. Of the Compounds III, the compound produced by hydrogenation of texasin, namely, 6,7-dihydroxy3-(4-methoxyphenyl)chromanon-4, having the structure
has been found to be particularly effective. Compounds III a novel compounds useful as antioxidants and as components of antioxidant compositions.
Finally, novel compounds having the structure
may be prepared by hydrogenation of Compounds III. Of these, the compound, 6,7-dihydroxy-3-(4-methoxyphenyl) chroman having the structure
is the most effective of the antioxidants which have been evaluated.
In accordance with another embodiment of this invention, antioxidant compositions may be prepared which include one or more of Compounds I and a suitable carrier. Furthermore, antioxidant compositions which include one or more of Compounds III and/or V provide exceptional antioxidative properties as set forth in the examples hereinafter. Suitable carriers include essentially all non-toxic substances with which the compounds may be admixed or in which they may be dissolved and/or suspended. When the antioxidant composition is intended for use in the stabilization of oils and fats the carrier may be the same or another compatible oil or fat. The amount of the compound or compounds present in the composition may vary within a wide range limited only by the requirement that the amount be effective to provide antioxidant properties to the composition. Typically, amounts will range from about 0.001 to 10 percent by weight.
Stabilized edible fat or oil compositions may be prepared by adding thereto an antioxidant composition which includes one or more of compounds I in an amount effective to stabilize such edible fat or oil. Effective amounts of such antioxidant compositions for improving the stability of oils or fats such as for example, lard, corn oil, olive oil, bean oil, safflower oil, vegetable oil, cottonseed oil, polyunsaturated oils, animal fats or oils and the like are amounts in the range of about 0.01 to 1.0 percent by weight, more or less.
Such antioxidant compositions can also be included in food products to produce stabilized food compositions. Accordingly, food products, such as fish, fatty meat or derivatives thereof, may be stabilized by the addition thereto of an effective amount of an antioxidant composition such as described hereinabove. Effective amounts may typically range from 0.001 to 10 percent by weight, preferably 0.01 to 1.0 percent.
As indicated hereinabove, Compounds II and certain of Compounds III are produced by fermentation of soybeans with a fungus,
e. g. , R. ligosporus or R. oryzae. Compounds II may then be recovered in the following manner. Dry, e.g. lyophilized, tempeh powder or cultured fungus is contacted with a 60-70% aqueous methanol solution for an extended period of time, for example, overnight, at a temperature of about 4°C. thereby producing an extract of methanol-soluble components including one or more of the isoflavones II. The methanol extract solution, after removal of insoluble material, is evaporated to dryness, preferably in vacuo, at an elevated temperature, for example, about 40-60°C. A solid residue is produced most of which is redissolved upon contact with dry methanol. That portion of the residue which is methanol insoluble is separated from the soluble components by centrifugation and discarded. After centrifugation, the methanol supernatant is extracted with haxane several times, for example, two to three times, in order to remove any traces of hexane-soluble impurities, such as lipids. After discarding the resulting hexan extract, the remaining methanol supernatant is evaporated to reduce its volume to a minimal fraction, for example, about 20 ml, and kept at a temperature of about -20°C. for about 15-20 minutes. This results in formation of additional precipitate which is removed and discarded.
The isoflavones may then be recovered from the methanol supe natant or extract as follows. The supernatant is subjected to molecular sieve chromatography, for example, chromatograp on Sephadex LH20 using a suitable size column, for example 2×40cm, and a suitable mobile phase, for example, n-propanol ethylacetate:water in a ratio 5:5:1. One of the fractions resulting from this chromatographic separation is fluorescen with emission in the blue range of the visible spectrum. This blue fluorescent fraction is separated and subjected to adsorption chromatography on a suitable matrix, for example, silica gel, using an appropriate mobile phase, e.g. ethylace tate:propanol:water = 95:2:3. The resulting blue fluorescen fraction is then rechromatographed on an adsorptive matrix, e.g. thin layer chromatography on silica gel, employing a
different mobile phase, e.g. cyclohexane:dichloromethane:ethylformate:formic acid = 35:30:30:5. Each of the isoflavones can then be recovered in essentially pure form using its differential mobility on the silica gel plate.
Alternatively, Compounds II can be chemically synthesized by forming a suspension of a compound having the structure
wherein each of R and R' may be either hydrogen or an ethyl or methyl group and a compound having the structure
wherein R" may be hydrogen, methyl or ethyl in dry ethylether containing zinc chloride. This suspension is then exposed to dry hydrogen chloride for a sufficient time to form an oily product. The suspension is next maintained at an appropriate temperature for a sufficient time to permit the oil product formed upon exposure to dry hydrogen chloride to separate from the suspension. The supernatant remaining after separation of the oil product from the suspension is removed and discarded. Next, a major amount of water and a minor amount of concentrated hydrochloric acid is added to the oil product to form a mixture, the mixture is boiled under reflux for a sufficient time to produce a precipitate product having the structure
After recovering this precipitate, it is dissolved in a suitable solvent, borontrifluoride-methyletherate added, the temperature adjusted to about 50°C, methanesulphonyl chloride added as a solution, and then the resulting solution heated at about 90-100°C. for a sufficient tims to permit the reaction to proceed substantially to completion. Finally, Compound II is recovered.
Compounds III can be prepared by hydrogenating Compounds II using conventional techniques such as contact with hydrogen gas in the presence of a catalyst under appropriate conditions of temperature, pressure and the like. Similarly, Compounds V can be prepared by hydrogenating Compounds III and/or II.
The following examples are set forth to illustrate the practices of the present invention but are not intended in any way to limit or otherwise restrict the scope thereof as set forth in the preceding description or in the claims which follow.
EXAMPLE I
The compounds 6,7-dihydroxy-3-(4-methoxyphenyl) chromanon-(4) and 6,7-dihydroxy-3(4-methoxyphenyl) chroman were evaluated a antoxidants using an automated version of the Swift stability test at 100°C. For a more detailed description of the Swift stability test see A.O.C.S. Tentative Method Cd 12-57 (revised 1959. For the test the lard was heated to 100°C. and air bubbled through at 2 ml/minutes. Every few hours the oil was analyzed for peroxide value using the peroxide value test, A.O.C.S. Official Method Cd8-53 (1960). The tests were car
ried out using two different batches of lard. The results of the tests are shown in Table I.
TABLE I AUTOMATED SWIFT STABILITY ON LARD End of Induction Period in Hours
CON CENT RATION OF ANTIOXIDANT
BATCH ANTTOXIDANT 25 mg/Kg 50 mgAg 100 mg/kg 200 m/kg
A 6,7-dihydroxy -3- (4-methoxy- 50 62 phenyl) chroman
6,7-dihydroxy3-(4-methoxyphenyl) chromanon-4 33 38
BHA 26 32.5
BHT 27 29
TBHQ 32 42 α-tocopherol (Vitamin E) 21 21
Blank ←2.5→
B 6,7-dihydroxy¬
3-(4-metho xyphenyl) chroman 26 43 92 110
6,7-dihydroxy -3- (4-methoxy- 62 phenyl) chroma- 15 22 45 non-4
BHA 10 30 49 57
Blank ←6.S→
According to the results obtained, 6 , 7-dihydroxy-3- (4-methoxyphenyl) chroman is the most effective of the antioxidants tested. 6 , 7-dihydroxy-3- (4-methoxyphenyl) chromanon-4 is better than α-tocopherol, but less effective than TBHQ and comparable with
BHA and BHT.
EXAMPLE 2
The Swift stability test descirbed for lard in Example 1 was repeated with palm oil and bean oil. The results again indicated that 6,7-dihydroxy-3-(4-methoxyphenyl)chroman is the most effective of the antioxidants. 6,7-dihydroxy-3-(4-methoxylphenyl)chromanon-4 was better than α-tocopherol, but less effective than TBHQ and comparable with BHA and BHT.
EXAMPLE 3
The compounds tested in Example 1, namely, 6,7-dihydroxy-3-(4-methoxyphenyl) chroman and 6,7-dihydroxy-3-(4-methoxyphenyl) chromanon-4, were also tested to evaluate their effect upon the taste of normal quality lard, bean oil and palm. oil. The compounds were added to the lard or oil at amounts ranging from 25-200 mg/kg and stored at 15°C. or 50ºC in the dark. The lard or oil was then tasted periodically over a 14-week period. It was found that 6,7-dihydroxy-3-(4-methoxyphenyl)chromanon-4 favorably influenced the taste of the lard and oils. Addition of 6,7-dihydroxy-3-(4-methoxyphenyl) chroman imparted an off-taste although this may be due to the presence of an impurity.
EXAMPLE 4
The same compounds were also evaluated to determine whether they would induce sterility and/or premature abortion of fetuses by feeding the compounds to female rats. In accordance with the Allen-Doisy Test ovarectomized rats were fed the compounds. No negative effect upon the production of female hormones or antifertility activity was noted. Additionally, feeding of the compounds to pregnant rats produced no abortive action.
EXAMPLE 5
The compounds 6,7-dihydroxy-3-(4-methoxyphenyl)-chromanon-(4) and 6,7-dihydroxy-3-(4-methoxyphenyl)-chroman were tested in lard using the Swift Stability Test at a series of concentrations. The results for two series of samples are shown in Tables II and III.
TABLE II
ANTIOXIDANT PROPERTIES OF 6,7-dihydroxy-3-(4-methoxyphenyl)-chroman
Concentration in Protection POV Stripped lard [2g] [percent] [megO2/kg]
0.5 mg = 250 ppm 96 1.9
0.2 mg = 100 ppm 96 98 2.2 1.0
0.1 mg = 50 ppm 86 6.4
0.05 mg = 25 ppm 38 33 32.8 30.5
0.02 mg = 10 ppm 22 41
None 0 0 52.6 45.4
TABLE III
ANTIOXIDANT PROPERTIES OF 6,7-dihydroxy-3-(4-methoxyphenyl)-chromanon-4
Concentration in Protection POV Stripped lard [2g] [percent] [megO2,/kg]
0.5 mg = 250 ppm 99 0.5
0.2 mg = 100 ppm 94 98 3.1 0.8
0.1 mg = 50 ppm 53 21.3
0.05 mg = 25 ppm 44 25 29.3 34.1
0.02 mg = 10 ppm 22 41
None 0 0 52.6 45.4
EXAMPLE 7 An antioxidant composition was obtained from tempeh which included Texasin and additional isoflavones having the structure
wherein R, R' and R" may be a methyl or ethyl group or hydrogen. This mixture of isoflavones was evaluated using the Swift Stability Test described hereinabove at 110°C. Lard samples containing 500, 50 and 1 ppm of the mixture were prepared by suitable dilutions of a stock mixture of the isoflavone mixture dissolved in 1:1 chloroform-methanol and the mixture was evaporated under vacuum to a clear solution. A similar set of lard samples containing BHT was also prepared for comparison Results of the test are shown in Table IV.
TABLE IV
Concentration Stability
Sample Antioxidant (ppm) (hours) Isoflavone mixture 500 36
50 22
1 22
BHT 500 1
50 35
1 24
Control 0 22
It may be seen that the isoflavone mixture at 50 ppm and 1 ppm produced no significant increase in stability. With the 500 ppm sample, however, the stability was comparable to that of the 50 ppm BHT sample. Thus, the isoflavone mixture has antioxidant properties, but its activity is less than that of BHT under conditions of the test. It should be noted that
this test is not completely suitable for evaluating isoflavones under all conditions because of the severity of the conditions used (temperature 110°C. with air bubbled through the sample).
EXAMPLE 8
An antioxidant composition was obtained from tempeh which included Texasin and trihydroxy-isoflavone. This mixture of isoflavones was evaluated using the Oven Storage Test described hereinabove at a temperature of 60°C. for 3 days. Peroxide values were determined for stripped lard samples containing the mixture. The results are set forth in Table V.
TABLE V
Concentration Protection
Stripped Lard [g] Antioxidant [mg] = ppm [percent]
1.0 0.5 250 98
1.5 0.25 125 96
1.8 0.10 50 49
EXAMPLE 9
A series of isoflavones either recovered from tempeh or chemically synthesized were evaluated using the Oven Storage Test for 40 hours and for 3 days at 60°C. In order to dissolve the isoflavones in 2 kg of stripped lard an emulsifier was employed such as a glycerol. The results are shown in Table VI.
TABLE VI ANTIOXIDANT PROPERTIES OF ISOFLAVONES
Amount % Protection (40h,60°C.) % Protection (3davs,60ºC)
Isoflavone Cone. SAMPLE. SAMPLE
[mg [% lard] 1 2 3 4 5 6 7 1 2 3 4 5 6 7
1.0 0.05 21 21 0 100 91 45 67 28 21 31 99 77 50 20 0.5 0.025 - - - 95 90 - 57 - - - 91 75 - 9 0.1 0.005 0 0 8 43 0 15 17 0 22 46 29 1 2 0 0.05 0.00025 - - - - - - 17 - - - - - - 0
1) 6-methoxy-7,4'-dihydroxyisoflavone (glycitein)
2) 7-methoxy-6,4'-dihydroxyisoflavone (kakkatin)
3) 6,7-dimethoxy-4'-hydroxyisoflavone
4) isoflavone mixture chemically synthesized without
5) 6,4'-dimethoxy-7-hydroxyisoflavone
6) isoflavone mixture from tempeh
7) 6,7,4'-trihydroxyisoflavone
The test results indicate that each of the isoflavones has a oxidant properties. Particularly effective is the isoflavon mixture obtained by chemical synthesis which includes various methoxy- substituted isoflavones. Also, the compound 6,4'-dimethoxy-7-hydroxyisoflavone was particularly effective.
EXAMPLE 10
Synthesis of 1,2,4-trihydroxybenzene
Fifty grams (0.46 mol) of 1,4-benzoquinone was slowly added with continuous stirring and cooling to a mixture consisting of 150 g acetic acid anhydride and 3 ml concentrated sulfuric acid. During this reaction the temperature should be maintained between 40 and 50°C. After all of the quinone has been dissolved and the heat development has ceased, the reaction mixture was poured into two liters of water and the precipiate formed was filtered off. After drying in a vacuum desicator one obtained 1,2,4-triacetoxybenzene in the form of a light brown amorphorus powder which may be recrystallized from methanol.
Eighty grams of the crude 1,2,4-triacetoxybenzene were dissolved in 200 ml of methanol containing 6g of concentrated sulfuric acid. The reaction mixture was boiled under reflux for one hour. Then the solution was cooled to room temperature and neutralized with an equivalent amount of fine powdered sodium carbonate. Thereafter 800 ml of ethylether was added whereupon sodium sulfate precipitated out, which was removed by filtration. Reaction by-products and contaminants being responsible for a dark red coloration may be removed employing solid silica gel. After evaporation of the supernatant under reduced pressure, a dark red oil is obtained which crystallized upon standing at 40°C. in the form of a slight reddish solid mass which is pure enough for the next step. This product is 1,2, 4-trihydroxybenzene.
EXAMPLE 11
Synthesis of 6 ,7-dihydroxy-4'-methoxyisoflavone (6,7-dihydroxy3-(4-methoxyphenyl)chromone)
35.4 grams of 1,2,4-trihydroxybenzene were suspended in 200 ml of dry ethylether containing 30g of dry zinc-chloride (0.22 mol) and 50g (0.34 mol) of p-methoxyphenylacetordtrile. The suspension was then exposed for 4 hours at 0°C. to a gentle stream of dry hydrogen chloride (HCl), the gas bubbling through the suspension under continuous stirring. Then the reaction mixture was kept for 70 hours at 4ºC. and thereafter the supernatant was decanted from the heavy oil which had separated. The oil was washed twice with ethylether, then one liter of water and a few ml of concentrated hydrochloric acid were added and the mixture boiled for 1 hour under reflux. After cooling to room temperature the precipitate was collected by filtration and recrystallized from ethanol/water. This precipitate was (4-methoxybenzyl)-2,4,5-trihydroxyphenyl ketone.
Four grams (14.6 milimol) of (4-methoxybenzyl)-2,4,5-tri-ydroxyphenyl ketone were dissolved in 50 ml. of dry dimethylformamide. To this solution was added 7.5 grams of borontri
fluoride-methyetherate (BF3-(CH3)2O dropwise. Under spontaneous elevation of the temperature the color of the solution turns to yellowish-green. Then the temperature of the reaction is adjusted to 50ºC. and a solution of 5 grams methanesulphonyl chloride (CH3SO2Cl) in 25 ml of dry di-methylformamide (DMF) is added dropwise. Thereafter, the solution is heated for 90 minutes at 90-100ºC. After cooling to room temperature, the reaction mixture is poured into 500 ml water and the resulting yellow precipitate is filtered off. After drying in a desicator the crude product is purified by boiling in 50 ml methanol and then 50 ml of ethyl ether. The resulting white powder can be recrystallized from dioxane or glacial acetic acid. This product is 6,7-dihydroxy-3-(4-methoxyphenyl) chromone (texasin).
EXAMPLE 12
Synthesis of 6 , 7-dihydroxy-3- (4-methoxyphenyl) chromanon-4
six grams of texasin (6,7-dihydroxy-3-(4-methoxyphenyl)chromone) were dissolved and partially suspended in 500 ml of ethanol and hydrogenated at normal pressure and room temperatur using 10% palladium/charcoal as a catalyst under addition of 6 drops of triethylamine. The catalytic hydrogenation is continued until no starting material is detectable by means of thin layer chromatography. Thereafter, the catalyst is removed by filtration, an equal amount of water is added to th reaction mixture and the solution is evaporated under reduce pressure. After removal of the largest part of the ethanol the product precipitates out in pure form. After filtration and drying in a desicator 5.5 grams of a light yellow powder is obtained which may be recrystallized once from ethanol/ water. The product has the formula C16 H1 4O5, molecular weight 286, and melting point 215°C. It was characterized by UV, NMR, IR and Mass spectroscopy and determined to be 6,7-dihydroxy(4-methoxyphenyl)-chromanon-4. The product is actually a mixture of optical isomers but since the isomers exhibit the same properties further characterization was not deemed necessary
for the purposes of this disclosure. Therefore it is to be understood that the scope of the disclosure and claims embraces the optical isomers of the compounds discussed herein.
EXAMPLE 13
Synthesis of 6,7-dihydroxy-3-(4-mehtoxyphenyl)chroman
Fifteen grams of texasin (6,7-dihydroxy-3-(methoxyphenyl)chromone) were dissolved and partially suspended in 500 ml of ethanol and hydrogenated at normal pressure and room temperature using 10% palladium/charcoal as a catalyst under addition of 20 drops of concentrated sulfuric acid. The catalytic hydrogenation is continued until neither texasin nor any of the 6, 7-dihydroxy-3-(4-methoxyphenyl)chromanon-4 was detected by thin layer chromatography. The further purification was identical to that described in Example 12. The product has the formula C16H16 O4, molecular weight 272, and melting point 160°C. It was characterized by UV, NMR, IR and Mass spectroscopy and determined to be 6,7-dihydroxy-3-(4-methoxyphenyl)chroman. As in Example 12, the product is actually a mixture of optical isomers but since the isomers exhibit the same properties further characterization was not deemed necessary for the purposes of this disclosure. Therefore, it is to be understood that the scope of the disclosure and claims embraces the optical isomers of the compounds discussed herein.
EXAMPLE 14
Synthesis of 5,7-dihydroxy-isoflavone
50 g (0.46 mol) 1,4 benzoquinone (XI) was slowly added with stirring to a mixture of 150 g of acetic anhydride and 3 ml of cone, sulfuric acid during which the reaction mixture was cooled so as to keep the temperature between 40 and 50°C. After all of the quinone was dissolved and the heat of formation evolved, the reaction product was washed with an excess of water and the precipitate removed by filtration. Upon drying the precipitate 1,2,4-triacetoxybenzone (XII) was obtained as a light brown powder which can be identified as such after crystallization from methanol. The yield from the reaction was 106 g (91%).
80 g (0.32 mol) of the crude product XII in 200 ml of methanol was heated under reflux for one hour in the presence of 6 g cone, sulfuric acid. The reaction mixture was neutralized with sodium carbonate and then ether added. Na2SO4 precipitated out and was separated by filtering. Known contaminants were removed by treatment with silica gel resulting in a solution having a dark red color. Upon distillation this solution yielded a dark red oil which rapidly crystallized to a light reddish solid material (XV) . The yield of this reaction was 35.4 g (88%).
35.4 g (0.28 mol) of Compound XIII was suspended with 30 g waterfree ZnCl2 (0.22 mol) in 200 ml dry ether and then mixed with 39.8 g (0.34 mol) benzylcyanide (XIV). Next, dry HCl gas was introduced in the reaction mixture with stirring for four hours at 0ºC. After about 70 hours storage in a refrigerator the re
maining solution was separated from the oil which had precipitated, washed two times with ether and heated one hour in 1 liter of water with which a few ml of HCl was mixed. After cooling the precipitate was removed by filtering and crystallized from alcohol/water. The yield of Compound XVwas 25 g (36.5%).
3.4 g (0.0146 mol) Compound XVwas dissolved in 50 ml dry DMF and 7.5 ml borontrifluoride-methyl-etherate added dropwise. Upon heating the solution assumed a yellow-green color. The solution was heated to 50ºC and then 5 g of methanesulfonyl chloride in 25 ml of DMF was added. Heating was continued for 90 minutes at 90-100°C and then the reaction mixture was cooled by adding about 0.5 liter water. The resulting yellow precipitate was removed by filtration and after drying yielded 3.1 g of a light brown powder which was purified by crystallization from methanol/water. This provided 3.0 g (81%) of Compound XVI, 6 , 7-dihydroxy-isoflavone.
EXAMPLE 15
6,7-dihydroxy-isoflavone may be hydrogenated using the methods described in Examples 12 and 13 to prepare the chromanon-4 and chroman respectively. Both of these compounds have been found effective as antioxidants at concentrations as low as 50 parts per million in the standard lard test described in Example 1.
As will be obvious to one skilled in the art, many modifications, variations, substitutions and other alterations can be made in the practices of this invention without departing from the spirit and scope thereof as set forth in the preceding description and examples or in the claims which follow.
Claims
1. A compound having the structure:
2. A compound in accordance with Claim 1 having the structure:
O
3. A compound in accordance with Claim 2 having the structure:
4. A compound in accordance with Claim 2 having the structure:
5. A compound in accordance with Claim 1 having the structure:
6. A compound in accordance with Claim 5 having the structure:
7. A compound in accordance with Claim 1 having the structure:
8. A compound in accordance with Claim 7 having the structure :
9. An antioxidant composition which comprises a compound in accordance with Claim 1 and a suitable carrier.
10. An antioxidant composition which comprises a compound in accordance with Claim 2 and a suitable carrier.
ll. An antioxidant composition which comprises a compound in accordance with Claim 3 and a suitable carrier.
12. An antioxidant composition which comprises a compound in accordance with Claim 4 and a suitable carrier.
13. An antioxidant composition which comprises a compound in accordance with Claim 5 and a suitable carrier.
14. An antioxidant composition which comprises a compound in accordance with Claim 6 and a suitable carrier.
15. An antioxidant composition which comprises a compound in accordance with Claim 7 and a suitable carrier.
16. An antioxidant composition which comprises a compound in accordance with Claim 8 and a suitable carrier.
17. A stabilized edible fat or oil composition which comprises an edible fat or oil and an antioxidant composition accordance with Claim 9, said antioxidant composition being present in an amount effective to stabilize said edible fat or oil.
18. A stabilized edible fat or oil composition which comprises an edible fat or oil and an antioxidant composition in accordance with Claim 10 , 11, 12, 13, 14, 15, or 16, said antioxidant composition being present in an amount effective to stabilize said edible fat or oil.
19. A stabilized edible fat or oil composition in accordance with Claim 17 wherein said edible fat or oil comprises animal fat or oil, vegetable oil, corn oil, cottonseed oil, lard, olive oil, soybean oil, bean oil, safflower oil, and polvunsaturated oils.
20. A stabilized edible fat or oil composition in accordance with Claim 17 wherein said antioxidant composition is present in an amount from about 0.01 percent to 1.0 percent by weight based upon the weight of said edible fat or oil.
21. A stabilized edible food product such as a fish or meat food product which comprises an edible food product and an antioxidant composition in accordance with Claim 9, said antioxidant composition being present in an amount effective to stabilize said edible food product.
22. A stabilized edible food product such as a fish or meat food product which comprises an edible food product and an antioxidant composition in accordance with Claim 10, 11, 12, 13, 14, 15 or 16, said antioxidant composition being present in an amount effective to stabilize said edible food product.
23. A stabilized edible food product in accordance with Claim 17 wherein said antioxidant composition is present in an amount from about 0.01 percent to 1.0 percent by weight based upon the weight of said edible fat or oil.
24. A method of stabilizing edible oils, fats or food products which comprises adding to said edible oils, fats or food products an effective amount of an antioxidant composition in accordance with Claim 9.
25. A method for preparing a compound in accordance with Claim 2 which comprises fermenting soybeans, contacting the resulting fermented soybean product with methanol to separate from said fermented soybean product an extract containing said compound and recovering said compound from said methanol extract.
26. A method in accordance with Claim 25 wherein said fermented soybean product is tempeh.
27. A method in accordance with Claim 25 wherein said extract containing said compound is obtained by contacting said fermented soybean product with an aqueous methanol solution at a temperature in the range about 0-10ºC., evaporating the resulting methanol extract solution to dryness to produce a residue, redissolving a portion of said residue in dry methanol, separating and discarding the methanol insoluble portion of said residue, contacting said dry methanol solution containing said redissolved residue with hexane to remove contaminating material, discarding the resulting hexane extract, reducing the volume of the remaining methanol extract at a reduced temperature for 10-30 minutes so as to produce a precipitate, removing and discarding said precipitate, and recovering said compound from the remaining extract.
28. A method in accordance with Claim 25 wherein said recovery of said compound from said methanol extract comprises chromatographic separation, said chromatographic separation being molecular sieve chromatography followed by adsorption chromatography.
29. A method of preparing a compound in accordance with Claim 2 which comprises forming a suspension of a compound having the structure:
wherein each of R, R' and R"' may be either hydrogen or an ethyl or methyl group and a compound having the structure:
wherein R" may be hydrogen or a methyl or ethyl group in dry ethylether containing zinc chloride, exposing said suspension to dry hydrogen chloride for a sufficient time to form an oily product, maintaining said suspension at an appropriate temperature for a sufficient time to permit said oil product formed upon exposure to dry hydrogen chloride to separate from said suspension, removing and discarding the supernatant remaining after separation of said oil product from said suspension, adding a major amount of water and a minor amount of concentrated hydrochloric acid to said oil product to form a mixture, boiling said mixture under reflux for a sufficient time to produce a precipitate product, said precipitate product having the structure:
and recovering said precipitate;
dissolving said precipitate product in a suitable solvent, adding borontrifluoride-methyletherate , adjusting the temperature to about 50°C . , adding methane sulphonyl chloride as a solution, heating the resulting solution at about 90-100°C . for a sufficient time to permit the reaction to proceed substantially to completion, and ecovering a compound having the structure:
30. A method of preparing a compound having the structure:
31. A method of preparing a compound having the structure:
32. A compound having the structure:
33. A compound in accordance with Claim 32 having the structure:
34. A compound in accordance with Claim 32 having the structure:
35. A compound in accordance with Claim 32 having the structure:
36. A compound in accordance with Claim 32 having the structure:
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BR7909002A BR7909002A (en) | 1979-04-11 | 1979-05-18 | ISOFLAVONES AND RELATED COMPOUNDS, PREPARATION AND USE PROCESS, AND ANTIOSIDANT COMPOSITES THAT CONTAIN THE SAME |
DE7979901460T DE2967100D1 (en) | 1979-04-11 | 1979-05-18 | Chroman and chromanon-4 derivatives, process for their preparation, antioxidant compositions containing same and their use for stabilizing edible fats and oils |
DK528880A DK528880A (en) | 1979-04-11 | 1980-12-11 | ISOFLAVONES AND RELATED COMPOUNDS PROCEDURES FOR THE PRODUCTION AND USE OF IT AND ANTIOXIDANT PRODUCTS WITH CONTENTS |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/029,122 US4264509A (en) | 1977-06-08 | 1979-04-11 | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same |
US29122 | 1979-04-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1980002098A1 true WO1980002098A1 (en) | 1980-10-16 |
Family
ID=21847353
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1979/000347 WO1980002098A1 (en) | 1979-04-11 | 1979-05-18 | Isoflavones and related compounds,methods of preparing and using and antioxidant compositions containing same |
Country Status (9)
Country | Link |
---|---|
US (1) | US4264509A (en) |
EP (1) | EP0027796B1 (en) |
JP (1) | JPS56500493A (en) |
AT (1) | ATE8324T1 (en) |
CA (1) | CA1140560A (en) |
DE (1) | DE2967100D1 (en) |
DK (1) | DK528880A (en) |
NL (1) | NL7906193A (en) |
WO (1) | WO1980002098A1 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0267155A2 (en) * | 1986-11-04 | 1988-05-11 | Zyma SA | Bicyclic compounds |
EP0426998A2 (en) * | 1989-11-10 | 1991-05-15 | Societe Des Produits Nestle S.A. | Process for the preparation of isoflavanones |
FR2720395A1 (en) * | 1994-05-31 | 1995-12-01 | Oreal | New compounds from the benzoheterocycles family. |
CN1094044C (en) * | 1998-03-15 | 2002-11-13 | 蛋白质技术国际公司 | Vegetable protein composition containing isoflavone depleted vegetable protein material with isoflavone containing material |
WO2003035635A1 (en) * | 2001-10-25 | 2003-05-01 | Novogen Research Pty Limited | 6-hydroxy isoflavones, derivatives and medicaments involving same |
WO2004030662A1 (en) * | 2002-10-02 | 2004-04-15 | Novogen Research Pty Ltd | Combination chemotherapy compositions and methods |
AU2003265737B2 (en) * | 2002-10-02 | 2008-10-16 | Novogen Research Pty Ltd | Combination chemotherapy compositions and methods |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
US8084628B2 (en) | 2004-09-21 | 2011-12-27 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
US9663484B2 (en) | 2010-11-01 | 2017-05-30 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
US10980774B2 (en) | 2015-02-02 | 2021-04-20 | Mei Pharma, Inc. | Combination therapies |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE40792E1 (en) * | 1992-05-19 | 2009-06-23 | Novogen Research Pty Ltd | Health supplements containing phyto-oestrogens, analogues or metabolites thereof |
US6140469A (en) * | 1993-10-12 | 2000-10-31 | Protein Technologies International, Inc. | Protein isolate having an increased level of isoflavone compounds and process for producing the same |
US5320949A (en) * | 1993-10-12 | 1994-06-14 | Protein Technologies International, Inc. | Process for producing aglucone isoflavone enriched vegetable protein fiber |
US5827682A (en) * | 1995-06-07 | 1998-10-27 | Protein Technologies International, Inc. | Two-step conversion of vegetable protein isoflavone conjugates to aglucones |
US5702752A (en) * | 1996-03-13 | 1997-12-30 | Archer Daniels Midland Company | Production of isoflavone enriched fractions from soy protein extracts |
US6261565B1 (en) | 1996-03-13 | 2001-07-17 | Archer Daniels Midland Company | Method of preparing and using isoflavones |
US5851792A (en) * | 1996-04-03 | 1998-12-22 | Shen; Jerome | Aglucone isoflavone enriched vegetable protein whey whey protein material aglucone isoflavone material high genistein content material and high daidzein content material and process for producing the same from a vegetable protein whey |
US6015785A (en) * | 1996-04-12 | 2000-01-18 | Protein Technologies International, Inc. | Aglucone isofavone enriched vegetable protein extract and isolate and process for producing |
US5821361A (en) | 1996-06-11 | 1998-10-13 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
AUPO203996A0 (en) * | 1996-08-30 | 1996-09-26 | Novogen Research Pty Ltd | Therapeutic uses |
US6146668A (en) | 1997-04-28 | 2000-11-14 | Novogen, Inc. | Preparation of isoflavones from legumes |
WO1998050026A1 (en) * | 1997-05-01 | 1998-11-12 | Novogen Inc | Treatment or prevention of menopausal symptoms and osteoporosis |
US6369200B2 (en) | 1997-10-15 | 2002-04-09 | Central Soya Company, Inc. | Soy isoflavone concentrate process and product |
US6320028B1 (en) | 1997-10-15 | 2001-11-20 | Central Soya Company, Inc. | Soy isoflavone concentrate process and product |
US6228993B1 (en) | 1998-10-12 | 2001-05-08 | Central Soya Company, Inc. | Soy isoflavone concentrate process and product |
AUPP112497A0 (en) * | 1997-12-24 | 1998-01-22 | Novogen Research Pty Ltd | Compositions and method for protecting skin from UV induced immunosupression and skin damage |
AUPP260798A0 (en) * | 1998-03-26 | 1998-04-23 | Novogen Research Pty Ltd | Treatment of medical related conditions with isoflavone containing extracts of clover |
US6083553A (en) * | 1998-06-05 | 2000-07-04 | Protein Technologies International, Inc. | Recovery of isoflavones from soy molasses |
US6001368A (en) * | 1998-09-03 | 1999-12-14 | Protein Technologies International, Inc. | Method for inhibiting or reducing the risk of macular degeneration |
US6703051B1 (en) | 1998-10-13 | 2004-03-09 | Solae, Llc | Process for separating and recovering protein and isoflavones from a plant material |
AUPP868599A0 (en) * | 1999-02-15 | 1999-03-11 | Novogen Research Pty Ltd | Production of isoflavone derivatives |
AUPQ008299A0 (en) * | 1999-04-30 | 1999-05-27 | G.J. Consultants Pty Ltd | Isoflavone metabolites |
US20090233999A1 (en) * | 1999-09-06 | 2009-09-17 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
AUPQ266199A0 (en) * | 1999-09-06 | 1999-09-30 | Novogen Research Pty Ltd | Compositions and therapeutic methods involving isoflavones and analogues thereof |
AUPQ520300A0 (en) * | 2000-01-21 | 2000-02-17 | Novogen Research Pty Ltd | Food product and process |
AUPR363301A0 (en) * | 2001-03-08 | 2001-04-05 | Novogen Research Pty Ltd | Dimeric isoflavones |
US20050119301A1 (en) * | 2001-03-16 | 2005-06-02 | Alan Husband | Treatment of restenosis |
CN1556699B (en) * | 2001-07-24 | 2010-05-12 | 嘉吉有限公司 | Process for isolating phenolic compounds |
WO2005103025A1 (en) * | 2004-04-21 | 2005-11-03 | Novogen Research Pty Ltd | Isoflavene synthetic method and catalyst |
US7528267B2 (en) * | 2005-08-01 | 2009-05-05 | Girindus America, Inc. | Method for enantioselective hydrogenation of chromenes |
US20070203227A1 (en) * | 2006-02-24 | 2007-08-30 | Herman Adlercreutz | Isoflavan and isoflavene compounds and their use as angiogenesis inhibitors |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3681085A (en) * | 1970-04-27 | 1972-08-01 | Paul Gyorgy | Food product containing tempeh |
US3762933A (en) * | 1971-06-21 | 1973-10-02 | P Gyorgy | Stabilized edible oil and fat compositions containing oil of tempeh |
-
1979
- 1979-04-11 US US06/029,122 patent/US4264509A/en not_active Expired - Lifetime
- 1979-05-16 CA CA000327756A patent/CA1140560A/en not_active Expired
- 1979-05-18 AT AT79901460T patent/ATE8324T1/en not_active IP Right Cessation
- 1979-05-18 WO PCT/US1979/000347 patent/WO1980002098A1/en unknown
- 1979-05-18 JP JP50186879A patent/JPS56500493A/ja active Pending
- 1979-05-18 DE DE7979901460T patent/DE2967100D1/en not_active Expired
- 1979-08-14 NL NL7906193A patent/NL7906193A/en not_active Application Discontinuation
-
1980
- 1980-10-23 EP EP79901460A patent/EP0027796B1/en not_active Expired
- 1980-12-11 DK DK528880A patent/DK528880A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3681085A (en) * | 1970-04-27 | 1972-08-01 | Paul Gyorgy | Food product containing tempeh |
US3762933A (en) * | 1971-06-21 | 1973-10-02 | P Gyorgy | Stabilized edible oil and fat compositions containing oil of tempeh |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, 7th Collective Index, Volumes 56-65, issued 1969 (Columbus, Ohio, USA). See pages 12, 259S-12, 262S. The Index, inter alia, lists 3 isoflavans, 6 isoflavanones and 12 isoflavones within the scope of the claims. * |
CHEMICAL ABSTRACTS, 8th Collective Index, Volumes 66-75, issued 1973 (Columbus, Ohio USA). See pages 16, 592S-16, 596S. The Index inter alia, lists 4 isoflavans, 3 isoflavanones and 14 isoflavones within the scope ofthe claims. * |
Cited By (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0267155A2 (en) * | 1986-11-04 | 1988-05-11 | Zyma SA | Bicyclic compounds |
EP0267155A3 (en) * | 1986-11-04 | 1988-07-20 | Zyma SA | Bicyclic compounds |
US4814346A (en) * | 1986-11-04 | 1989-03-21 | Zyma Sa | Benzopyrans and use thereof in treating vascular diseases |
EP0426998A2 (en) * | 1989-11-10 | 1991-05-15 | Societe Des Produits Nestle S.A. | Process for the preparation of isoflavanones |
EP0426998A3 (en) * | 1989-11-10 | 1991-07-31 | Societe Des Produits Nestle S.A. | Process for the preparation of isoflavanones |
CH679584A5 (en) * | 1989-11-10 | 1992-03-13 | Nestle Sa | |
EP0478003A1 (en) * | 1989-11-10 | 1992-04-01 | Societe Des Produits Nestle S.A. | Process for the protection of a food product |
FR2720395A1 (en) * | 1994-05-31 | 1995-12-01 | Oreal | New compounds from the benzoheterocycles family. |
EP0685473A2 (en) * | 1994-05-31 | 1995-12-06 | L'oreal | Benzoheterocyclic compounds, as antioxidants |
EP0685473A3 (en) * | 1994-05-31 | 1995-12-27 | Oreal | |
US5523319A (en) * | 1994-05-31 | 1996-06-04 | Lore L | Compounds of the benzo-heterocycle family |
CN1094044C (en) * | 1998-03-15 | 2002-11-13 | 蛋白质技术国际公司 | Vegetable protein composition containing isoflavone depleted vegetable protein material with isoflavone containing material |
WO2003035635A1 (en) * | 2001-10-25 | 2003-05-01 | Novogen Research Pty Limited | 6-hydroxy isoflavones, derivatives and medicaments involving same |
WO2004030662A1 (en) * | 2002-10-02 | 2004-04-15 | Novogen Research Pty Ltd | Combination chemotherapy compositions and methods |
AU2003265737B2 (en) * | 2002-10-02 | 2008-10-16 | Novogen Research Pty Ltd | Combination chemotherapy compositions and methods |
US7906554B2 (en) | 2002-10-02 | 2011-03-15 | Novogen Research Pty Ltd | Combination chemotherapy compositions and methods |
US8080675B2 (en) | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
US8084628B2 (en) | 2004-09-21 | 2011-12-27 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
US8461361B2 (en) | 2004-09-21 | 2013-06-11 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
US8697891B2 (en) | 2004-09-21 | 2014-04-15 | Marshall Edwards, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
US8957109B2 (en) | 2004-09-21 | 2015-02-17 | Mei Pharma, Inc. | Chroman derivatives, medicaments and use in therapy |
US9138478B2 (en) | 2004-09-21 | 2015-09-22 | Mei Pharma, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
US9198895B2 (en) | 2004-09-21 | 2015-12-01 | Mei Pharma, Inc. | Chroman derivatives, medicaments and use in therapy |
US9381186B2 (en) | 2004-09-21 | 2016-07-05 | Mei Pharma, Inc. | Substituted chroman derivatives, medicaments and use in therapy |
US9708283B2 (en) | 2010-11-01 | 2017-07-18 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US9663484B2 (en) | 2010-11-01 | 2017-05-30 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
US9981936B2 (en) | 2010-11-01 | 2018-05-29 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US10105346B2 (en) | 2010-11-01 | 2018-10-23 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
US10369132B2 (en) | 2010-11-01 | 2019-08-06 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US10973799B2 (en) | 2010-11-01 | 2021-04-13 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US11583514B2 (en) | 2010-11-01 | 2023-02-21 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
US11723893B2 (en) | 2010-11-01 | 2023-08-15 | Mei Pharma, Inc. | Isoflavonoid compositions and methods for the treatment of cancer |
US10980774B2 (en) | 2015-02-02 | 2021-04-20 | Mei Pharma, Inc. | Combination therapies |
Also Published As
Publication number | Publication date |
---|---|
CA1140560A (en) | 1983-02-01 |
JPS56500493A (en) | 1981-04-16 |
ATE8324T1 (en) | 1984-07-15 |
NL7906193A (en) | 1980-10-14 |
EP0027796B1 (en) | 1984-07-11 |
EP0027796A4 (en) | 1981-08-31 |
DE2967100D1 (en) | 1984-08-16 |
DK528880A (en) | 1980-12-11 |
EP0027796A1 (en) | 1981-05-06 |
US4264509A (en) | 1981-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4390559A (en) | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same | |
EP0027796B1 (en) | Chroman and chromanon-4 derivatives, process for their preparation, antioxidant compositions containing same and their use for stabilizing edible fats and oils | |
US4366082A (en) | Isoflavones and related compounds, methods of preparing and using and antioxidant compositions containing same | |
US4366248A (en) | Fermentation method of preparing antioxidants | |
US4157984A (en) | Antioxidants, antioxidant compositions and methods of preparing and using same | |
US4232122A (en) | Antioxidants, antioxidant compositions and methods of preparing and using same | |
US4218489A (en) | Antioxidants, antioxidant compositions and methods of preparing and using same | |
AU2003218777B2 (en) | A process for the preparation of tomato extracts with high content in lycopene | |
US7544822B2 (en) | Recovery of phytonutrients from oils | |
KR100719860B1 (en) | Method for extracting unsaponifiable matters from vegetable oils using chloro-1-butane, composition containing said unsaponifiable matters | |
US4234577A (en) | Ergostadientriols, compositions containing same, and methods of preparing and using same | |
JP4796695B2 (en) | Method for recovering plant sterols | |
EP1363895B1 (en) | Process for the production of tocotrienols | |
US4708820A (en) | Method of producing phenol-type natural antioxidative materials from processed sesame seed products | |
US2411969A (en) | Process for the preparation of synthetic dl-tocopherols | |
US4368264A (en) | Fermentation methods of preparing ergostadientriols | |
US7138532B2 (en) | Color-stable, low impurity tocopherol compositions and processes for preparing the same | |
US2411970A (en) | 7, 8-dimethyl tocol and process for the preparation of the same | |
US2349273A (en) | Process for preparing tocopherols and new tocopherol derivatives | |
US2353011A (en) | Process for refining fat-soluble vitamin-containing materials | |
US2245147A (en) | Chemical compositions and process for their preparation | |
JPH05156247A (en) | New benzopyrane derivative | |
JPS6157309B2 (en) | ||
JPS59227876A (en) | Separation of tocopherols | |
JPS58132076A (en) | Anti-oxidizing composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): BR DK JP |
|
AL | Designated countries for regional patents |
Designated state(s): AT CH DE FR GB LU SE |